<?xml version="1.0" encoding="UTF-8"?>
<ref id="B21-pharmaceutics-13-00379">
 <label>21.</label>
 <element-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Ballard</surname>
    <given-names>C.G.</given-names>
   </name>
   <name>
    <surname>Gauthier</surname>
    <given-names>S.</given-names>
   </name>
   <name>
    <surname>Cummings</surname>
    <given-names>J.L.</given-names>
   </name>
   <name>
    <surname>Brodaty</surname>
    <given-names>H.</given-names>
   </name>
   <name>
    <surname>Grossberg</surname>
    <given-names>G.T.</given-names>
   </name>
   <name>
    <surname>Robert</surname>
    <given-names>P.</given-names>
   </name>
   <name>
    <surname>Lyketsos</surname>
    <given-names>C.G.</given-names>
   </name>
  </person-group>
  <article-title>Management of agitation and aggression associated with Alzheimer disease</article-title>
  <source>Nat. Rev. Neurol.</source>
  <year>2009</year>
  <volume>5</volume>
  <fpage>245</fpage>
  <lpage>255</lpage>
  <pub-id pub-id-type="doi">10.1038/nrneurol.2009.39</pub-id>
  <?supplied-pmid 19488082?>
  <pub-id pub-id-type="pmid">19488082</pub-id>
 </element-citation>
</ref>
